Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: miR-133a silencing rescues glucocorticoid-induced bone loss by regulating the MAPK/ERK signaling pathway

Fig. 1

miR-133a expression in glucocorticoid-treated MSCs and animal models. a Western blotting analysis for osteogenesis and adipogenesis-related proteins in MSCs after treatment with DEX. b Relative levels of miR-133a in MSCs after DEX treatment. c Relative levels of miR-133a in the serum of rats after methylprednisolone intramuscular injection. d Relative levels of miR-133a in MSCs transfected with the miR-133a antagomir (each condition was performed in triplicate, *P < 0.05 relative to the control or blank group)

Back to article page